HomeHealth NewsTreatment-resistant IBD may benefit from new combo antibody therapy

Treatment-resistant IBD may benefit from new combo antibody therapy

May 7, 2026

- Advertisement -

A new study indicates that a combo therapy approach may be better for treating Crohn’s and ulcerative colitis. BONNINSTUDIO/Stocksy

Current treatments for inflammatory bowel disease (IBD) focus on reducing inflammation and relieving symptoms through therapies such as medications.
However, some people with IBD, which includes ulcerative colitis and Crohn’s disease, don’t respond to any type of therapy.
Two new studies found that a combination of two medications may offer better results in…

- Advertisment -